CTRad has four workstreams that focus on different aspects of radiotherapy research; they meet all together at least once a year, and individually two to four times per year.
The science base workstream focuses on preclinical studies, radiation-drug interactions, radiobiology, biomarkers and imaging and physics and imaging.
Nicola Curtin (co-chair)
Tim Humphrey (consumer member)
The phase I/II studies workstream focusses on phase I/II studies, experimental cancer medicine, biomarkers and imaging and systemic therapies and radiotherapy.
Richard Adams (co-chair)
Sarah Brown (co-chair)
Tim Ward (consumer member)
The phase III trials and methodology workstream focusses on phase III trials, links with NCRI Groups and trials methodology development for evaluating novel radiotherapy approaches.
Robert Huddart (co-chair)
Yat Man Tsang (co-chair)
Richard Stephens (consumer member)
The new technology, physics and quality assurance workstream focusses on new technologies (e.g. proton therapy, stereotactic body radiotherapy, functional imaging), quality assurance, radiotherapy physics and databases.
Karen Kirkby (co-chair)
Julie Wolfarth (consumer member)